Related Experiment Video
Updated: Aug 13, 2025

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Noradrenergic Modulation of Learned and Innate Behaviors in Dopamine Transporter Knockout Rats by Guanfacine
Anna Volnova1,2, Natalia Kurzina1, Anastasia Belskaya1
1Institute of Translational Biomedicine, Saint Petersburg State University, Saint Petersburg 199034, Russia.
Guanfacine, a noradrenergic drug, improved attention and memory in dopamine transporter knockout rats. This suggests a potential new therapeutic strategy for attention deficit and hyperactivity disorder (ADHD) by balancing dopamine and norepinephrine.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Attention deficit and hyperactivity disorder (ADHD) mechanisms are not fully understood.
- Dopamine transporter knockout (DAT-KO) rats exhibit ADHD-like behaviors.
- Noradrenergic modulation may offer therapeutic benefits.
Purpose of the Study:
- To investigate the effects of guanfacine on DAT-KO rats.
- To evaluate noradrenergic modulation of behavioral deficits.
- To explore guanfacine's impact on spatial working memory and innate behaviors.
Main Methods:
- Rats (DAT-KO and wild type) were trained in a spatial working memory task (Hebb-Williams maze).
- Innate behavior was assessed using pre-pulse inhibition (PPI).
- Brain activity in the prefrontal cortex and striatum was measured.
Main Results:
- Repeated guanfacine administration improved spatial working memory and PPI in DAT-KO rats.
- Guanfacine induced changes in brain activity power spectra and coherence.
- Both acute and repeated guanfacine treatments showed behavioral improvements.
Conclusions:
- Guanfacine demonstrates a compensatory effect in hyperdopaminergic rats.
- This study supports the role of norepinephrine-dopamine balance in attention.
- Findings may inform combined treatment strategies for ADHD.
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Drugs Affecting Neurotransmitter Synthesis
Neurochemical Transmission: Sites of Drug Action

